The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/IIa, open label, clinical trial evaluating the safety and efficacy of autologous T cells expressing enhanced TCRs specific for NY-ESO-1 in patients with recurrent or treatment refractory ovarian cancer (NCT01567891).
 
Kunle Odunsi
Research Funding - ITeos Therapeutics (Inst)
 
Mihaela C. Cristea
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Trovagene
 
Oliver Dorigo
No Relationships to Disclose
 
Amir A. Jazaeri
Consulting or Advisory Role - EMD Serono; Roche
Research Funding - AstraZeneca
 
Brian M. Slomovitz
No Relationships to Disclose
 
Karen Chagin
Employment - Adaptimmune
 
Erin Van Winkle
Employment - Adaptimmune; Shire
 
Gabor Kari
Employment - Adaptimmune
 
Malini Iyengar
Employment - Adaptimmune
 
Elliot Norry
Employment - Adaptimmune; GlaxoSmithKline
 
Arundathy N. Bartlett-Pandite
Employment - Adaptimmune; GlaxoSmithKline
Stock and Other Ownership Interests - Adaptimmune; GlaxoSmithKline
 
Rafael G. Amado
Employment - Adaptimmune; GlaxoSmithKline